PE-22-28 10mg
Research Studies:
- Selective TREK-1 potassium channel antagonist for investigating antidepressant-like signaling pathways
- Facilitates analysis of hippocampal brain-derived neurotrophic factor expression and activation
- Supports research on glutamatergic neurotransmission modulation and synaptic plasticity in assays
- Enables evaluation of rapid-acting neurogenic responses within controlled cellular assay models